4893 items matching your search terms.

HER2 extracellular domain: a predictive marker of lapatinib treatment benefit in advanced breast cancer

Lee, CK Davies, L Gebski, V Lord, S Di Leo, A Johnston, S Geyer, C Cameron, D Press, M Ellis, C Simes, J De Souza, P

Development and validation of prognostic nomograms to predict survival outcomes in patients with locally advanced or metastatic gastrointestinal stromal tumor receiving first line imatinib therapy

Lee, CK Joensuu, H McArthur, G Montemurro, M Yip, D Goldstein, D Bylina, E Andrzejuk, J Siedlecki, JA Rutkowski, P

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis

Lee, C. K. Brown, C. Gralla, R. J. Hirsh, V. Thongprasert, S. Tsai, C. M. Tan, E. H. Ho, J. C. Chu da, T. Zaatar, A. Osorio Sanchez, J. A. Vu, V. V. Au, J. S. Inoue, A. Lee, S. M. Gebski, V. Yang, J. C.
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013     DOI:10.1093/jnci/djt072

Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone

Lee, C. K. Gebski, V. J. Coates, A. S. Veillard, A. S. Harvey, V. Tattersall, M. H. Byrne, M. J. Brigham, B. Forbes, J. Simes, R. J. Australia New Zealand Breast Cancer Trials, Group,
SPRINGERPLUS, 2013     DOI:10.1186/2193-1801-2-391

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

Lee, C. K. Simes, R. J. Brown, C. Gebski, V. Pfisterer, J. Swart, A. M. Berton-Rigaud, D. Plante, M. Skeie-Jensen, T. Vergote, I. Schauer, C. Pisano, C. Parma, G. Baumann, K. Ledermann, J. A. Pujade-Lauraine, E. Bentley, J. Kristensen, G. Belau, A. Nankivell, M. Canzler, U. Lord, S. J. Kurzeder, C. Friedlander, M.
ANNALS OF ONCOLOGY, 2013     DOI:10.1093/annonc/mds538

Hypertensive disease of pregnancy is associated with decreased risk for respiratory distress syndrome in moderate preterm neonates

Liu, A. Carlsson, E. Nilsson, S. Oei, J. Bajuk, B. Peek, M. Martin, A. Nanan, R. NSW and the ACT Neonatal Intensive Care Units (NICUS) Group,
HYPERTENSION IN PREGNANCY, 2013     DOI:10.3109/10641955.2013.784786

Patient versus clinician preferences for chemotherapy in non-small-cell lung cancer

Long, A. Ferraro, D. Stockler, M. Blinman, P.
LUNG CANCER MANAGEMENT, 2013     DOI:10.2217/lmt.13.6

Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects

Lopes-Virella, M. F. Baker, N. L. Hunt, K. J. Cleary, P. A. Klein, R. Virella, G. DCCT/EDIC Research Group,
DIABETES CARE, 2013     DOI:10.2337/dc12-2521

The metabolic syndrome and CVD outcomes for a central Australian cohort

Luke, J. Brown, A. Daniel, M. O'Dea, K. Best, J.D. Jenkins, A. Wang, Z. McDermott, R. Wang, Z. Rowley, K.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013     DOI:10.1016/j.diabres.2013.03.020

The role of macrophages in docetaxel resistance in castrate resistant prostate cancer

Mahon, K Chatfield, M Breit, S Brown, DA Molloy, MP Marx, G. Pavlakis, N Boyer, M Stockler, M Horvath, L

Performance of the Parent Report of Children's Abilities-Revised (PARCA-R) versus the Bayley Scales of Infant Development III

Martin, A.J. Darlow, B.A. Salt, A. Hague, W. Sebastian, L. McNeill, N. Tarnow-Mordi, W.
ARCHIVES OF DISEASE IN CHILDHOOD, 2013     DOI:10.1136/archdischild-2012-303288

Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis [correction 2104; 200: 205]

Martin, A.J. Lord, S.J. Verry (Carter), H.E. Stockler, M.R. Emery, J.D.
MEDICAL JOURNAL OF AUSTRALIA, 2013     DOI:10..5694/mja12.11597

Quality-adjusted survival as an end point in breast cancer trials

Martin, A.J. Simes, R.J.
CLINICAL INVESTIGATION, 2013     DOI:10.4155/CLI.13.37

Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small cell lung cancer

McCaughan, G.J. Blinman, P.L. Boyer, M.J. Stockler, M.R.
INTERNAL MEDICINE JOURNAL, 2013     DOI:10.1111/j.1445-5994.2012.02846.x.

Patients' preferences for adjuvant chemotherapy in early non-small-cell lung cancer: what makes it worthwhile?

McLachlan, SA Hughes, B Crombie, C Christmas, T Hudson, M Brown, C Veillard, AS Muljadi, N Millward, M Wright, G Flynn, P Windsor, M Stockler, M Blinman, P